ArticleCardiology research2026
Left Atrial Deformation Parameters After Myocardial Infarction With Low Triiodothyronine Syndrome and Their Prognostic Value.
Article in Cardiology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute myocardial infarction (AMI) management has reduced in-hospital mortality, yet heart failure (HF) and atrial fibrillation (AF) remain common long-term complications. Left atrial (LA) function, assessed via speckle-tracking echocardiography (STE), provides sensitive markers of cardiac remodeling. This study aims to investigate the prognostic value of LA deformation parameters and their significance for long-term outcomes in patients with ST-segment elevation myocardial infarction (STEMI), particularly in relation to low triiodothyronine (T3) syndrome. Methods: A retrospective study enrolled 140 first-onset STEMI patients treated with primary percutaneous coronary intervention. Thyroid hormone concentrations were measured within 24 h of admission, and patients were classified into low T3 (free triiodothyronine (fT3) < 3.2 pmol/L, n = 44) and control groups (n = 96). Echocardiography and STE were performed within 72 h and repeated after 6 months. LA reservoir strain and conduit and contractile strain rate parameters were analyzed. Long-term outcomes, including AF, rehospitalization, HF, major adverse cardiac events (MACEs), and all-cause death, were assessed after 10 years. Results: Patients with low T3 syndrome were older, with higher inflammatory markers (P = 0.03) and reduced LA conduit strain rates during the acute phase (P = 0.04). After 6 months, LA volume increased significantly in both groups, but more prominently in low T3 patients (P = 0.03). Reduced LA reservoir strain (area under the curve (AUC), 0.721; P = 0.012) and conduit strain rate (AUC, 0.621; P = 0.012) were strong predictors of MACEs and AF, respectively. Logistic regression identified the LA conduit strain rate, LA reservoir strain, LA volume index, and left ventricular ejection fraction as independent predictors of adverse outcomes. Conclusions: STE-derived LA deformation parameters provide valuable prognostic information in post-STEMI patients. The LA reservoir strain and LA conduit strain rate are significant predictors of MACEs, while LA global longitudinal strain identifies patients at risk of HF. Early STE evaluation can enhance risk stratification and guide management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.